Fenwick & West has advised Epitel. Epitel, a leader in AI-driven wireless brain health technologies, has completed a $26 million Series B funding round. The capital...
Epitel Raises $26 Million in Series B Funding to Expand Wireless Brain Health Solutions
EDX Markets Secures $76 Million in Series C Funding Led by SBI Holdings
Fenwick has advised EDX Markets. EDX Markets, a prominent digital asset technology company specializing in institutional trading platforms, has completed a $76 million Series C funding...
WorkOS Raises $100 Million in Series C Funding at $2 Billion Valuation
Fenwick & West has advised WorkOS. WorkOS has completed a $100 million Series C funding round, bringing its valuation to $2 billion. The capital raised was...
FriendliAI Raises $20 Million in Seed Funding Round
Fenwick & West has advised FriendliAI on the transaction. FriendliAI, a company specializing in high-performance AI inference platforms, has secured $20 million in a seed funding...
Samaya AI’s $43.5 Million Funding Round
Fenwick & West represented Samaya AI in the transaction. Samaya AI, an artificial intelligence platform for financial services, announced raising $43.5 million in funding. The round...
Johnson & Johnson’s $13.1 Billion Acquisition of Shockwave Medical
Freshfields Bruckhaus Deringer is representing Johnson & Johnson in the transaction, and Fenwick & West is representing Shockwave Medical. Johnson & Johnson (NYSE: JNJ) and Shockwave Medical,...
Eyconis’ Formation and Launch
Fenwick & West represented Eychonis, Inc. in the transaction. Eyconis, Inc. announced their formation and $150 million capital raise. Eyconis was formed and launched by Ascendis...
Blink Mobility’s Acquisition of Envoy Technologies
Fenwick represented Envoy Technologies on the deal. Envoy Technologies, a software and mobility service company offering shared electric vehicles as amenity for national real estate developers...
Cisco’s Acquisition of Lightspin
Fenwick advised Cisco Systems, Inc. on the deal. Cisco Systems, Inc. (NASDAQ: CSCO), a worldwide leader in technology, announced its pending acquisition of Lightspin, a privately-held...
Third Harmonic Bio’s $213.1 Million IPO
Fenwick represented Third Harmonic Bio, Inc. on the deal. Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT...